DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients
Canberk Sencan, Fatma Sena Dost, Esra Ateş Bulut, Ahmet Turan Işık
Topics & Concepts
SarcopeniaMedicineGlycemicInternal medicineType 2 Diabetes MellitusDiabetes mellitusDipeptidyl peptidase-4 inhibitorRetrospective cohort studyEndocrinologyDiabetes Treatment and ManagementNutrition and Health in AgingPeptidase Inhibition and Analysis